Piper Serica is a holding company that operates through its subsidiaries, focusing on the acquisition and operation of companies in various sectors. The company aims to create long-term value for its shareholders through strategic investments and operational improvements.

Piper Serica

Thomas Keller Restaurant Group operates multiple restaurants and culinary establishments, focusing on fine dining and high-quality culinary experiences. The group includes The French Laundry, Bouchon Bistro, and Ad Hoc, among others.

Thomas Keller Restaurant Group

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.

Piper Serica is a boutique asset manager investing across public and private markets in India.

In the public markets, the house manages a SEBI registered PMS and also advises a Mauritius based offshore fund investing in long only listed equities in India.

The company also manages Piper Serica Angel Fund, a SEBI registered AIF investing in early stage startups.

Collectively, Piper Serica manages over INR 1000 crore in assets and is among the best alternate asset managers in India



Metric
Company Name	Piper Serica	Thomas Keller Restaurant Group	TransMedics Group, Inc.
Symbol			TMDX
MSH ID	COM:PIPERSERICA	COM:THOMASKELLER	COM:TRANSMEDICS
Market	PRIVATE	PRIVATE	STOCKS
Sector	Commercial & Professional Services	Consumer Services	Healthcare
Industry	Diversified Holdings	Food & Beverage	Medical - Devices
Country	IN	US	US
Stage
Employee Count	17		584
Website	piperserica.com	thomaskeller.com	transmedics.com
LinkedIn	piper-serica-advisors-pvt-ltd-
Founders

Metric
Market Cap			4.56B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue			241.62M
Revenue (LTM)
Revenue (NTM)
Gross Profit			153.99M
EBITDA			8.76M
Operating Income			485K
Net Income			-25.03M
EPS			-0.77
Diluted EPS			-0.77
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.64
Operating Profit Margin			-0.00
EBITDA Margin			0.04
Net Profit Margin			0.01
Return on Equity			0.02
Return on Assets			0.00
Return on Capital Employed			-0.00

COM:PIPERSERICA

Piper Serica

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-79.07
P/B Ratio			22.37
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			17.60
EV Multiple			3.76K

Metric
Days Sales Outstanding			115.41
Days Payables Outstanding			72.13
Days Inventory Outstanding			184.46
Operating Cycle			280.50
Cash Conversion Cycle			229.17
Asset Turnover			0.47

Metric
Operating Cash Flow			-13.03M
Free Cash Flow			-192.09M
Cash Flow to Debt			0.05
Operating Cash Flow/Sales			0.07
Free Cash Flow Yield			-0.01

Metric
Cash & Equivalents			394.81M
Accounts Receivable			-33.82M
Inventory			44.23M
Goodwill			11.99M
Debt to Capitalization			0.79
Debt to Assets			0.75
Current Ratio			10.93
Quick Ratio			8.76

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.06
R&D to Revenue			0.30
SG&A to Revenue			0.29